ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,431.60
-0.04%
Dow Jones
38,589.16
-0.15%
US Dollar vs MXN
18.4648
0.00%
Brent Oil
82.275
0.00%
Bitcoin
66,452.05
0.40%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Acadia Pharmaceuticals Inc (ACAD)

  7. Acadia Pharmaceuticals Inc (ACAD) Noticias

ACAD Acadia Pharmaceuticals Inc

14.87
-0.22 (-1.46%)
14 Jun 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Acadia Pharmaceuticals Inc ACAD NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.22 -1.46% 14.87 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
15.01 14.81 15.12 14.91 15.09
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
11/6/202417:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/5/202417:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/5/202417:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/5/202417:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/5/202417:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/5/202417:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/5/202417:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/5/202415:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/5/202416:23EDGAR2Form 8-K - Current report
29/5/202415:55EDGAR2Form S-8 POS - Securities to be offered to employees in..
29/5/202415:54EDGAR2Form S-8 POS - Securities to be offered to employees in..
29/5/202415:53EDGAR2Form S-8 POS - Securities to be offered to employees in..
29/5/202415:53EDGAR2Form S-8 POS - Securities to be offered to employees in..
29/5/202415:53EDGAR2Form S-8 POS - Securities to be offered to employees in..
29/5/202415:53EDGAR2Form S-8 POS - Securities to be offered to employees in..
29/5/202415:53EDGAR2Form S-8 POS - Securities to be offered to employees in..
29/5/202415:53EDGAR2Form S-8 POS - Securities to be offered to employees in..
29/5/202415:02EDGAR2Form S-8 - Securities to be offered to employees in employee..
17/5/202415:05BWAcadia Pharmaceuticals Reports Inducement Grants Under..
15/5/202408:05BWAcadia Pharmaceuticals Announces Launch of Magnolia's Guide..
09/5/202415:58BWAcadia Pharmaceuticals to Participate at Upcoming Investor..
08/5/202415:10EDGAR2Form 8-K - Current report
08/5/202415:05BWAcadia Pharmaceuticals Reports First Quarter 2024 Financial..
29/4/202415:16BWAcadia Pharmaceuticals is Proud to Announce the Winners of..
24/4/202415:05BWAcadia Pharmaceuticals to Announce First Quarter Financial..
22/4/202408:04BWAcadia Pharmaceuticals Announces Trofinetide New Drug..
19/4/202415:05BWAcadia Pharmaceuticals Reports Inducement Grants Under..
17/4/202415:05BWAcadia Pharmaceuticals Presents New DAYBUE™ (trofinetide)..
02/4/202415:05BWAcadia Appoints Elizabeth H. Z. Thompson, Ph.D. as Executive..
01/4/202415:05BWAcadia Pharmaceuticals to Participate in the 23rd Annual..
15/3/202415:05BWAcadia Pharmaceuticals Reports Inducement Grants Under..
13/3/202415:05BWAcadia Pharmaceuticals to Participate in the UBS Virtual CNS..
12/3/202406:21IHMARKETNEWSOracle Soars 13% With Exceptional Growth and Boosts Nvidia..
11/3/202415:05EDGAR2Form 8-K - Current report
11/3/202415:05BWAcadia Pharmaceuticals Announces Top-Line Results from Phase..
29/2/202408:05BWAcadia Pharmaceuticals to Participate in TD Cowen’s 44th..
27/2/202417:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202417:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202417:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202417:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202415:16EDGAR2Form 8-K - Current report
27/2/202415:05BWAcadia Pharmaceuticals Reports Fourth Quarter and Full Year..
21/2/202415:05BWAcadia Pharmaceuticals Reports Inducement Grants Under..
14/2/202406:08EDGAR2Form SC 13G - Statement of acquisition of beneficial..
13/2/202415:05BWAcadia Pharmaceuticals to Announce Fourth Quarter and Full..
08/2/202416:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202416:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
30/1/202420:55EDGAR2Form 8-K - Current report
30/1/202419:48BWAcadia Announces Additions to Executive Team
26/1/202416:25EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..

Su Consulta Reciente

NASDAQ
ACAD
Acadia Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados